Early Access — free while we kick the tires
EdgarHawk

CANGANY PETER T JR

Director

Director
4 filings analyzed · 1 company · Latest 2024-11-25

Companies

Company Buys Sells Direction
Beneficient BENF 9 0 Net buying

Activity

November 2024
2024-11-25 Beneficient BENF
high
Buy
25,000 shares
$23,750
Significance 7/10

Director CANGANY PETER T JR bought 25,000 shares at $0.95 on 2024-11-22; stock down -97.9% from 52-week high.

Director CANGANY PETER T JR purchased 25,000 shares at $0.95, expanding his stake to 325,000 shares (+8.3% vs pre-transaction holdings). This buy occurs amid severe price deterioration: the stock trades at $8.16 against a 52-week high of $390.02, representing a -97.9% decline from peak, with 30-day and 90-day losses of -17.7% and -46.3% respectively. Notably, CANGANY has a strong track record at this same ticker: his prior 3 measurable buys at BENF all yielded positive 90-day returns (ranging from +234.8% to +476.6%), and he was well-timed on 100% of those trades. However, context is critical: the company reported full-year unprofitability despite posting $9.7M net income in the latest quarter and $8.6M quarterly revenue, and the stock has cratered in the current environment. The purchase at $0.95 follows two buys three days prior (2024-11-19) at the same ticker, suggesting continued accumulation despite downward momentum.

2024-11-20 Beneficient BENF
high
Buy
75,000 shares
$69,500
Significance 7/10

Director Peter Cangany buys 75,000 shares (75.0K) at blended $0.93, tripling holdings to 100,000 shares after stock dropped 98.3% from $390.02 high

CANGANY PETER T JR purchased 75,000 shares through two separate transactions on 2024-11-19 for $69,500.00 total at a blended average price of $0.93, expanding his holdings from 25,000 to 100,000 shares (+300.0%). The timing of this purchase is striking: the stock trades at $6.59, down 98.3% from its 52-week high of $390.02, and has fallen 36.1% in the past 30 days and 67.3% over 90 days. Across his prior trades at BENF, Cangany has demonstrated strong timing acumen—his 5 prior transactions at this ticker show positive returns at the 90-day measurement point (ranging from +234.8% to +11324.0%), with a 100% win rate at that interval. However, investors should note the company reported full-year net income was negative in its most recent fiscal year, despite the current quarter showing $9.7M net income; this backdrop of fundamental weakness combined with the stock's massive drawdown from $390 to current levels creates material uncertainty about whether prior timing success will repeat.

August 2024
2024-08-28 Beneficient BENF
high
Buy
30,000 shares
$59,100
Significance 7/10

BENF director Cangany acquires 30,000 shares in 2 purchases at $1.97; holdings triple to 50.0K shares; prior same-ticker buys showed +18152.8% and +17598.5% 30-day returns.

Director Peter T. Cangany Jr. executed 2 separate purchases totaling 30,000 shares for $59,100.00 on 2024-08-27, tripling his holdings from 20,000 to 50,000 shares at a blended average price of $1.97. This follows a pattern of recent accumulation: Cangany purchased shares on 2024-08-20 and 2024-08-19, and in February 2024 his same-ticker buys at BENF generated 30-day returns of +18152.8% and +17598.5%. The current stock price of $12.48 represents a -99.4% decline from the 52-week high of $2080.00 and a -52.7% decline over 30 days, suggesting material recent deterioration in valuation. His prior two measurable same-ticker purchases at BENF both exhibited strong positive outcomes within 30 and 90 days, establishing a historical pattern at this specific ticker.

2024-08-21 Beneficient BENF
critical
Buy
27,500 shares
$62,655
Significance 8/10

Director CANGANY PETER T JR acquired 27,500 shares at blended $2.28, doubling stake to 50,000 shares; stock down 99.1% from $2080.00 high.

Director CANGANY PETER T JR completed 2 separate purchases totaling 27,500 shares for $62,655.02 on August 19–20, 2024, raising his holdings from 22,500 to 50,000 shares (a +122.2% increase). The transactions occurred at $2.28 blended average, while the stock currently trades at $18.51—but this masks a severe trajectory: the security has collapsed 99.1% from its 52-week high of $2080.00 and declined 42.4% in the prior 30 days alone. Notably, the insider's 2 prior trades at this same ticker (February 2024) both achieved exceptional 90-day returns of +18152.8% and +11324.0%, demonstrating a strong historical pattern of timing entry points before major recoveries. The company's latest quarter shows mixed metrics (revenue $10,046,000.00 with net income of $44,310,000.00) yet the full-year results are negative, and annual revenue declined 5.9%, creating fundamental headwinds alongside the dramatic price action. This purchase, following the same ticker's prior well-timed entries, represents a material commitment during a period of extreme volatility and negative momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access